Nexcella Announces Complete Response in 9th Relapsed

Nexcella Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting

Format

PNG

Nexcella, Inc.